Gail M Farfel is Chief Executive Officer of ProMIS Neurosciences, Inc.
Person profile
Roles
Address
New Haven, Connecticut
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
DURECT CORP
27 Sep 24
4
ProMIS Neurosciences Inc.
25 Aug 23
4
DURECT CORP
23 Jun 23
4
AVROBIO, Inc.
8 Jun 23
4
ProMIS Neurosciences Inc.
16 Dec 22
4
ProMIS Neurosciences Inc.
8 Dec 22
4
ProMIS Neurosciences Inc.
20 Sep 22
3
ProMIS Neurosciences Inc.
20 Sep 22
4
DURECT CORP
17 Jun 22
4
AVROBIO, Inc.
10 Jun 22
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 25 Sep 24 | DRRX DURECT | Stock Option Common Stock | Grant | Acquire A | No | No | 1.22 | 5,500 | 6.71 k | 5,500 |
| 23 Aug 23 | PMN ProMIS Neurosciences | Common Shares | Grant | Acquire A | No | No | 0 | 53,192 | 0.00 | 55,192 |
| 23 Aug 23 | PMN ProMIS Neurosciences | Warrants to purchase Common Shares Common Shares | Grant | Acquire A | No | No | 1.75 | 53,192 | 93.09 k | 53,192 |
| 21 Jun 23 | DRRX DURECT | Stock Option Common Stock | Grant | Acquire A | No | No | 5.29 | 5,500 | 29.10 k | 5,500 |
| 6 Jun 23 | TECX Tectonic Therapeutic | Stock Option Common Stock | Grant | Acquire A | No | No | 1.09 | 17,643 | 19.23 k | 17,643 |